GlassScriptPhysician profile
Itzel Martinez
NPI 1063299113
$916.30
in general payments reported to CMS, 2019-2025
22 companies · $21.94 in 2025
The $21.94 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $473 · 2024: $422 · 2025: $21.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $128.39 | 2023-2024 | Nayzilam, Rystiggo |
| Kestra Medical Technology Services, INC. | $121.41 | 2024 | Assure Wcd |
| Argenx US, INC. | $93.90 | 2023-2024 | Vyvgart Hytrulo |
| Abbvie INC. | $70.58 | 2023-2024 | |
| Eisai INC. | $55.80 | 2023 | |
| Alexion Pharmaceuticals, INC. | $55.47 | 2023 | Ultomiris |
| Ge Healthcare | $46.67 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $41.76 | 2023-2024 | Xywav |
| Amneal Pharmaceuticals LLC | $30.77 | 2023-2024 | Rytary |
| Neurelis, INC. | $25.93 | 2024 | Valtoco |
| Harmony Biosciences LLC | $24.69 | 2023 | Wakix |
| Vanda Pharmaceuticals INC. | $23.09 | 2024 | Hetlioz |
| Lundbeck LLC | $22.58 | 2023 | Rexulti |
| Amgen INC. | $22.51 | 2024 | Uplizna |
| Beta Bionics, INC. | $21.94 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $21.75 | 2024 | Evrysdi |
| Otsuka America Pharmaceutical, INC. | $21.19 | 2023 | Nuedexta |
| Scilex Pharmaceuticals INC. | $20.62 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $20.08 | 2024 | Lumryz |
| Kyowa Kirin, INC. | $17.14 | 2023 | Nourianz |
| Novartis Pharmaceuticals Corporation | $16.40 | 2023 | |
| Pfizer INC. | $13.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itzel Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.